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Abstract:  Malnutrition is a serious condition in chronic obstructive pulmonary disease (COPD). 
Successful dietary intervention calls for calculations of resting metabolic rate (RMR). One 
  disease-specific prediction equation for RMR exists based on mainly male patients. To construct 
a disease-specific equation for RMR based on measurements in underweight or weight-losing 
women and men with COPD, RMR was measured by indirect calorimetry in 30 women and 11 men 
with a diagnosis of COPD and body mass index ,21 kg/m2. The   following variables,   possibly 
influencing RMR were measured: length, weight, middle upper arm circumference, triceps 
  skinfold, body composition by dual energy x-ray absorptiometry and bioelectrical impedance, 
lung function, and markers of inflammation. Relations between RMR and measured variables 
were studied using univariate analysis according to Pearson. Gender and variables that were 
associated with RMR with a P value ,0.15 were included in a forward multiple regression 
analysis. The best-fit multiple regression equation included only fat-free mass (FFM): RMR 
(kJ/day) = 1856 + 76.0 FFM (kg). To conclude, FFM is the dominating factor influencing RMR. 
The developed equation can be used for prediction of RMR in underweight COPD patients.
Keywords: pulmonary disease, chronic obstructive, basal metabolic rate, malnutrition, body 
composition
Introduction
Chronic obstructive pulmonary disease (COPD) is one of the leading causes of death 
in Sweden as well as in many other countries.1–3 Women seem to be more   susceptible 
than men to develop COPD,4,5 and in Sweden more women than men die from COPD.1 
It has recently been shown that patients with COPD suffer a tremendous disease burden 
manifested by higher rates of all-cause and respiratory-related health care utilization 
and costs, and a high prevalence of comorbidities.6 Almost 50% of all COPD patients 
become underweight, and several studies have shown that a low body mass index (BMI) 
or body composition with low fat-free mass index (FFMI), is a major mortality risk 
factor.7–9 In a previous study of our group we demonstrated a great variation in total 
energy expenditure, physical activity, energy intake and resting metabolic rate (RMR) 
among underweight patients with COPD living at home.10 It is important to estimate 
both the resting energy expenditure and the level of physical activity for approxima-
tion of the total energy needs in an individual patient.11 DLW (doubly labeled water) is 
considered to be the golden standard for assessment of total daily energy expenditure 
(TDE) but is too complicated and expensive to be performed in clinical praxis. RMR can 
be measured by indirect calorimetry, but this is not commonly an available method in 
the clinic. A reliable prediction equation of RMR is therefore of importance to establish International Journal of Chronic Obstructive Pulmonary Disease 2010:5 submit your manuscript | www.dovepress.com
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an adequate nutritional support. There are several equations 
available to predict RMR, ie, WHO,12 Harris and Benedict,13 
Moore and Angelillo,14 and Westerterp.15 The equation from 
Moore and Angelillo is the only one that is disease specific to 
predict RMR in COPD patients. It was developed based on a 
study with COPD patients with a majority of men. The aim of 
the present study was to develop a COPD-specific prediction 
equation for RMR in COPD patients with low body weight 
or great involuntary weight loss and to validate the equa-
tion in another group of COPD patients and to compare it 
with other prediction equations. We wanted the equation to 
be suitable for the clinical setting and to be based on RMR 
measurements in both men and women since earlier studies 
have mostly included men, and the problem with COPD in 
women is increasing.
Materials and methods
The Committee for Medical Research Ethics at University of 
Gothenburg approved the study. The patients were informed 
of the nature and purpose of the study and written informed 
consent was given.
Patients
The patients in this study and the validation group were 
both recruited from the out-patient unit at the Department 
of Respiratory Medicine, Sahlgrenska University Hospital, 
Göteborg, Sweden.
The inclusion criteria were: diagnosis of COPD, smoking 
history of .10 pack years, age over 45 years, a spirometry 
test performed during the last 12 months showing a FEV1/
FVC ratio less than 0.7, FEV 1.0 , 60% of predicted normal 
and BMI , 21 kg/m2, or involuntary weight loss of .10% 
over 3 months. Inclusion criteria for the validation group 
were the same except for the BMI criterion.
The exclusion criteria were inability to perform inves-
tigations without oxygen supply, inability to get to the 
hospital 3 times during 1 week, inability to contribute at the 
investigations, other severe diseases such as malignancy in 
an unstable phase, chronic heart failure, metabolic disease, 
or renal failure. Exclusion criteria for the validation group 
were the same with the addition of exclusion of patients with 
oxygen treatment at home.
study design
The investigation for each patient took place during one week, 
and the patients visited the hospital on 3 different days. The 
patients had to be fasting during 12 hours before arrival to 
the hospital on all 3 visits. On arrival they were interviewed 
concerning any signs of infection during the last 2 weeks. 
If they reported any signs of infection during this period, the 
inclusion was postponed.
Anthropometric measurements
Length was measured to the nearest 0.5 cm using a   horizontal 
headboard with an attached wall-mounted metric rule. 
Patients were weighed, without shoes and in underwear, on a 
digital balance to the nearest 0.1 kg (Weighcare, Newhaven, 
England). BMI was calculated as weight (kg) divided by 
height2 (m). Middle upper arm circumference (MAC) was 
measured with a tape measure and triceps skinfold (TS) was 
measured with a Harpenden Skinfold Caliper 2 cm above 
midway between the acromion and olecranon; the average 
of 3 measurements was recorded.
Pulmonary function tests
Arterial blood gases (partial pressure of oxygen (pO2) and 
partial pressure of carbon dioxide (pCO2)) were measured 
in all patients. Spirometry was performed on a spirometer 
SensorMedics model 922, (SensorMedics Co, Palm Springs, 
USA), except on the last patient where a spirometer Jae-
ger Masterscope (VIASYS, Hoechberg, Germany) was 
used. Prediction normal values according to the European 
Respiratory Society equations16 were used. In the study 
group, minute volume (L min−1) was also measured with 
equipment consisting of a Research Pneumotach System 
(RSS 100HR, Hans Rudolf, Kansas City, MO, USA) and 
a heated pneumotachygraph (type 3850AF and 3700A, 
Hans Rudolf).17
rMr
RMR was measured by indirect calorimetry using a 
  ventilated-hood system at the first and second visit. The 
equipment used was a DeltatracTM II Metabolic Monitor 
(Datex, Helsinki, Finland). Before each measurement, the 
equipment was calibrated with gas mixtures of known O2 and 
CO2 contents according to the manufacturer’s   instructions. 
All subjects were measured after an overnight fast. After a 
30-minute rest in the supine position, RMR was measured 
during 30 minutes when the subjects were awake in the 
supine position. The measurements were performed in 
an   environmental temperature between 22°C–23°C. The 
presented mean RMR for each patient is based on the last 
25 minutes of the measurement. The lowest RMR of the 
2 measurement occasions was used as the outcome   variable. 
RMR was then calculated in the study and validation group 
using the WHO equations.12 In the validation group, RMR International Journal of Chronic Obstructive Pulmonary Disease 2010:5 submit your manuscript | www.dovepress.com
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was also calculated using the equations of Harris and Bene-
dict,13 Moore and Angelillo,14 and Westerterp.15
Body composition
Body composition was measured with dual energy x-ray 
absorptiometry (DXA) (Lunar Prodigy, GE Lunar Corp, 
Madison, USA). In the validation group of COPD patients, 
body composition was also measured by single-frequency 
bioelectrical impedance assessment (BIA) in the morning 
after a 10 minute rest in the supine position. Impedance was 
measured by one single measurement of resistance (in ohms) 
and reactance (in ohms) with a BIA-101 equipment (Akern, 
Florence, Italy). The 4 electrodes were attached on the dorsal 
side of the foot, the ankle, the hand, and the wrist at the right 
side of the body. Fat-free mass (FFM) was calculated using 
manufacturer supplied equations based on comparison with 
densitometry in a normal population. FFMI was calculated 
as FFM (kg) divided by height2 (m).
Medication and nicotine use  
(study group)
During 24 hours prior to the second visit, the patients regis-
tered every dose of nicotine and medication use.
Markers of inflammation (study group)
Levels of high-sensitive C-reactive protein (hs-CRP) were 
measured in serum with a latex reagent (Roche Diagnostics, 
Germany) using a modular PP analyzer (Roche, Japan) at the 
accredited laboratory at the Department of Clinical   Chemistry, 
Sahlgrenska University Hospital. The   intra-assay CV of the 
CRP method was 2% at 1 mg/L and 1% at 20 mg/L. The 
amount of neutrophils was obtained from a blood   differential 
test at the same laboratory.
High sensitivity ELISA was used to analyze tumor necro-
sis factor alpha (TNF-α) (R&D Systems HSTA00D) and 
Interleukin 6 (IL-6) (R&D Systems HS600B) in serum.
statistics and validation
Data are expressed as mean and standard deviations (SDs). 
To explore relations between RMR and possible measured 
variables, univariate analysis using Pearson correlation 
analysis were performed. Variables that were associated 
with RMR with a P , 0.15 and gender were included in a 
forward multiple linear regression analysis. The prediction 
equation produced from this study was then validated in 
another sample of COPD patients. Both the FFM resulting 
from the DXA and the BIA were tested when validating the 
prediction equation. The validation was performed by paired 
t-tests and agreements plots, and the results from the newly 
produced equation were also compared with other existing 
RMR prediction equations.
Results
Predicting BMr in COPD
42 patients (31 women, 11 men) were included during 
the period February 2004 to December 2006. One patient 
(woman) with widespread lung cancer diagnosed after the 
first visit was excluded. Patient characteristics are presented 
in Table 1. The males had higher body weight, body height, 
BMI, and FFMI, compared with the females. 15 patients 
were active smokers, 5 patients used nicotine substitutes, 
and 6 patients were snuff users. The cigarette consumption 
in the smokers during 24 hours before RMR measurements 
was on average 11 cigarettes (range 1–23).
Variables related to RMR in the univariate analysis are 
presented in Table 2. The best-fit multiple regression equation 
included only FFM and explains 64.7% of the variation in 
RMR, with a standard error of the estimate at 448.5 kJ:
RMR (kJ/day) = 1856 + 76.0 FFM (kg)
Validation and comparison  
with other prediction equations
Validation was performed in a sample of 44 patients with 
COPD (29 women, 15 men). Patient characteristics are 
presented in Table 3. The males had higher body height and 
FFMI compared with the females. The 2 patient samples were 
not statistically significantly different in age and body height, 
but differed with regard to body weight, BMI, FFMI, and 
FEV1. The new equation underestimates RMR using FFM 
assessed by DXA (Table 4). Since none of the patients in the 
original sample from where we produced the equation were 
obese, we decided to exclude patients with a BMI . 30 kg/m2 
(1 male and 2 females) from the validation material and redo 
the analysis. This resulted in an acceptable estimation of 
Table 1 Patient characteristics, mean (sD)
All subjects  
(n = 41)
Female  
(n = 30)
Male  
(n = 11)
Pa
Age (years) 63.5 (8.8) 62.9 (8.6) 65.2 (9.4) 0.47
Body weight (kg) 52.4 (7.8) 49.7 (6.7) 59.7 (5.6) 0.000080
Body height (cm) 167.7 (8.0) 165.0 (6.4) 175.2 (7.4) 0.00010
BMI (kg/m2) 18.8 (2.0) 18.5 (2.1) 19.8 (1.1) 0.045
FeV1 (% predicted) 39 (15) 40 (15) 36 (15) 0.48
FFMI (kg/m2) 14.0 (1.8) 13.2 (1.3) 16.2 (1.1) 0.000000017
Abbreviations:  sD,  standard  deviation;  BMI,  body  mass  index;  FeV1,  forced 
expiratory volume in 1 second; FFMI, fat-free mass index.
aUnpaired t-test females versus males.International Journal of Chronic Obstructive Pulmonary Disease 2010:5
Table  2  Pearson  correlation  coefficients  reaching  statistical 
significance  (P  ,  0.05)  between  BMr  (kJ)  and  other  possible 
explaining factors measured
Correlation coefficient   
with BMR (kJ) 
Fat free mass (kg) 0.799 (P , 0.01)
Body weight (kg) 0.714 (P , 0.01)
Body height (m) 0.709 (P , 0.01)
FVC (L) 0.562 (P , 0.01)
Package years 0.443 (P , 0.01)
Arm circumference (cm) 0.419 (P , 0.01)
Minute volume (L/min) 0.374 (P , 0.05)
BMI (kg/m2) 0.369 (P , 0.05)
FeV1 (L) 0.334 (P , 0.05)
Neutrophiles (n) −0.298 (P = 0.06)
Triceps skinfold (mm) −0.269 (P = 0.09)
Abbreviations: BMr, basal metabolic rate; FVC, forced vital capacity; BMI, body 
mass index; FeV1, forced expiratory volume in 1 second.
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  circumference, breathing minute volume, BMI, FEV1, 
  neutrophils, and triceps skin fold showed a lower degree of 
influence, and neither of the variables improved the strength 
of prediction. That FFM is the most important   determinant 
of   resting metabolic rate is in line with other studies. 
  Creutzberg et al found in a study of 172 COPD patients 
that FFM explained 51% of the variation in resting energy 
expenditure.18 According to Schols et al FFM explained 84% 
of the variation in resting metabolic rate in a healthy control 
group and 34% of the variation in COPD patients.19 Both these 
studies, as well as the current study, included patients having 
severe or very severe COPD according to GOLD-guidelines. 
Although FFM seems to be the major factor predicting RMR 
in COPD patients, FFM does not seem to explain variations in 
RMR as well in COPD patients as in healthy individuals. This 
indicates that in COPD, factors other than FFM have larger 
impact on RMR than in healthy persons. We have however been 
unable to identify such factors in the current study. It should 
be noted that the patients in the current study had low FFMI. 
55% of the males and 93% of the females had FFMI below 
the suggested reference values for COPD patients.20
The patients in our study seem to differ from those in 
other studies in that FFM explained more of the variation 
in RMR. This is especially evident in comparison with the 
study by Schols et al.19 Hypermetabolism has frequently 
been described in COPD patients especially in weight-losing 
patients in which measured RMR has been compared with 
RMR predicted according to the formula by Harris and 
Benedict.13 Our patient group differs also from these results. 
There was a close   correlation between measured RMR and 
Table  3  Patient  characteristics  of  the  validation  population, 
mean (sD)
All subjects  
(n = 37)
Female  
(n = 26)
Male  
(n = 11)
Pa
Age (years) 66.5 (7.2) 66.0 (7.3) 67.9 (6.8) 0.46
Body weight (kg) 65.7 (15.5)b 62.7 (13.6) 72.7 (15.2) 0.071
Body height (cm) 165.6 (8.2) 162.0 (6.3) 174.3 (5.1) 0.0000020
BMI (kg/m2) 23.8 (4.2)b 23.8 (4.0) 23.8 (4.8) 1.0
FeV1 (% predicted) 44 (15) 45 (16) 42 (15) 0.67
FFMI (kg/m2) 15.4 (2.1)b 14.7 (1.4) 17.0 (2.5) 0.00091
aUnpaired t-test females versus males. bP , 0.01 (unpaired t-test, validation population 
versus prediction population).
Abbreviations:  sD,  standard  deviation;  BMI,  body  mass  index;  FeV1,  forced 
expiratory volume in 1 second; FFMI, fat-free mass index.
Table 4 Measured and predicted BMr in a validation population 
of COPD patients (n = 37), and in the same sample of COPD 
patients where the obese patients have been excluded (n = 34), 
mean (sD)
BMR (kJ)  
(n = 37)
Pa BMR (kJ)  
(n = 34)
Pa
Measured BMr  5399 (1205) – 5193 (890) –
Current equation, using  
FFM from DXA
5140 (783) 0.049 5062 (721) 0.23
Current equation, using  
FFM from BIA
5393 (822)b 0.91 5259 (676)c 0.26
harris and Benedict13 5321 (918) 0.41 5182 (760) 0.90
WhO12 5653 (882) 0.0010 5507 (687) 0.0015
Westerterp15 (based on  
FFM from DXA)
5767 (1127) 0.0017 5622 (995) 0.00039
Moore and Angelillo14 6169 (1092) ,0.001 6012 (955) ,0.001
aPaired t-test between measured and predicted BMr. bn = 34 due to technical error 
with the BIA. cn = 31 due to technical error with the BIA.
Abbreviations: BMr, basal metabolic rate; COPD, chronic obstructive pulmonary 
disease;  sD,  standard  deviation;  FFM,  fat-free  mass;  DXA,  dual  energy  x-ray 
absorptiometry; BIA, bioelectrical impedance assessment.
BMR, on group level, both when using the FFM from DXA 
and BIA (Table 4). The equations from WHO,12 Westerterp,15 
and Moore and Angelillo14 clearly overestimates RMR and 
were therefore not analyzed in agreement plots.
Figure 1 illustrates the difference between measured and 
predicted RMR. There are small differences in agreement 
between the different equations shown. The current equation 
using FFM from DXA underestimates RMR by 131 (SD 563) kJ 
while using FFM from BIA induces an overestimation of 68 
(SD 505) kJ. This could be compared to the Harris and Benedict 
equation, which overestimates RMR by 42 (SD 494) kJ. There 
are no systematic patterns of the agreements over the range of 
RMR in either of the equations; hence we conclude that each 
of the 3 variants predicts RMR as good as another.
Discussion
The main finding of the present study is that FFM explained 
64.7% of the inter-individual variation in resting metabolic 
rate. Body weight, body height, FVC, package years, arm International Journal of Chronic Obstructive Pulmonary Disease 2010:5 submit your manuscript | www.dovepress.com
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RMR predicted from the   Harris and Benedict formula13 in our 
study. The disease-  specific prediction formula by Moore and 
Angelillo14 on the other hand would have overestimated RMR 
in the present patient group as had the equations by WHO12 
and Westerterp.15
The explanation for these differences between our patient 
group and other groups is not quite clear. It should be noted 
that we in this study have a relatively high proportion of 
women. The difference in the proportion of men and women 
in the studies seem to be of minor importance. Gender had 
little influence on RMR. Some possibly contributing factors 
may be mentioned. No patients with evidence of ongoing 
exacerbations were included in the present study. Only 36% 
of the patients were active smokers, and the amount of ciga-
rettes smoked during the 24 hours before recording of RMR in 
those who smoked was only 11 cigarettes in average. It should 
however be noted that this result is based on self-report with no 
  subjective marker of nicotine ingestion. Smoking habits were 
not reported in the other mentioned studies. Only 1 patient in 
our study was included because of known recent weight loss. 
We have, however, no information concerning the weight 1 year 
before entering the study of the remaining patients. The ratio 
of weight-losing/weight-stable patients is thus unknown. This 
could explain why the RMR in our patient group was lower 
than in the group of weight-losing COPD patients in the study 
mentioned above but not that RMR in our study group was 
lower than that of the weight-stable patients in that study.19 We 
have also noted that systemic inflammation in our patient group 
seem to be less marked than in other studies.21 TNF-α was on 
average 2.5 pg/mL for male (n = 11) and 1.6 pg/mL in female 
(n = 30) subjects (P = 0.17). Our results might thus be influenced 
by few known weight-losing patients, few active smokers, and 
with evidence of less marked systemic inflammation than in 
other reported groups of COPD patients in other countries. Also, 
since the studied sample are relatively small, further   validation 
  studies in larger and more mixed population of COPD patients 
is needed to confirm the findings in this study.
The Harris and Benedict equation for predicting BMR 
gave results surprisingly similar to those produced with our 
prediction formula. The Harrison and Benedict equation is 
based on age, height, weight, and gender and developed from 
studies on normal healthy individuals in the first 2 decades of 
the 20th century. The average BMI in the Harris and Benedict 
population was 22 kg/m2 when calculating BMI from average 
length and weight in the material collected from all series 
in the article. According to modern views, several of the 
persons included thus were underweight and in this respect 
similar to the present malnourished group of COPD patients. 
This might explain why the Harris and Benedict equation 
had the smallest difference compared with predicted RMR 
from our equation (Table 4), since the average BMI in our 
material also was low, 18.8 kg/m2. The Harris and Benedict 
formula furthermore includes age as an important factor for 
  predicting BMR. By increasing age, muscle mass diminishes, 
and as a result of that also RMR. Including age as a factor in 
a prediction formula thus indirectly uses FFM for prediction 
of RMR, which also might explain the close correlation with 
our prediction formula that is only based on FFM.
The results of the present study thus give further evidence 
to the view that RMR in COPD patients is not uniform. The 
prediction formula of this study seems to be best suited for 
malnourished but weight stable COPD patients. In patients 
still losing weight, our prediction formula might underestimate 
RMR. Actually measuring RMR is however recommended.
Harris & Benedict equation
−1500
−1000
−500
0
500
1000
1500
2000
2500
8000 6000 4000
Mean of measured and predicted BMR (kJ)
M
e
a
s
u
r
e
d
 
B
M
R
 
m
i
n
u
s
 
p
r
e
d
i
c
t
e
d
 
B
M
R
 
(
k
J
)
Mean diff (SD): 11 (511) kJ
Current equation, using FFM from BIA
−1500
−1000
−500
0
500
1000
1500
2000
2500
8000 6000 4000
Mean of measured and predicted BMR (kJ)
M
e
a
s
u
r
e
d
 
B
M
R
 
m
i
n
u
s
 
p
r
e
d
i
c
t
e
d
 
B
M
R
 
(
k
J
)
 
Mean diff (SD): −105 (513) kJ
Current equation, using FFM from DXA
−1500
−1000
−500
0
500
1000
1500
2000
2500
8000 6000 4000
Mean of measured and predicted BMR (kJ)
M
e
a
s
u
r
e
d
 
B
M
R
 
m
i
n
u
s
 
p
r
e
d
i
c
t
e
d
 
B
M
R
 
(
k
J
)
Mean diff (SD): 131 (623) kJ
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